
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type from the provided ranked marker list, we will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **KRT17, KRT14, KRT5, KRT7**: These are keratins, which are structural proteins typically expressed in epithelial cells. They play a role in maintaining cell integrity and are often used as markers for epithelial cell types.<br>- **ACTG2, ACTA2**: These are actin proteins, with ACTA2 (alpha-smooth muscle actin) being a marker for smooth muscle cells and myofibroblasts.<br>- **MT2A, MT1X, MT1E**: Metallothioneins involved in metal ion homeostasis and protection against oxidative stress.<br>- **CAV1, CAV2**: Caveolins are involved in the formation of caveolae (small invaginations in the cell membrane) and are associated with various signaling pathways.<br>- **SFN (14-3-3 sigma)**: Involved in cell cycle control and apoptosis.<br>- **TAGLN (Transgelin)**: A marker for smooth muscle cells and myofibroblasts.<br>- **SAA1 (Serum Amyloid A1)**: An acute-phase protein involved in inflammation.<br>- **ITGA2, ITGB1**: Integrins involved in cell adhesion and signaling.<br>- **CXCL8, CXCL2, CXCL1**: Chemokines involved in immune cell recruitment and inflammation.<br>- **MYC**: A transcription factor involved in cell proliferation.<br>- **CRYAB (Alpha B-crystallin)**: A small heat shock protein involved in stress response.<br>- **NNMT (Nicotinamide N-methyltransferase)**: Involved in cellular metabolism.<br>- **TNFRSF12A (TWEAK receptor)**: Involved in inflammation and apoptosis.<br>- **FHL2**: A transcriptional coactivator involved in various cellular processes.<br>- **TUBB6, TUBB4B**: Tubulins involved in microtubule formation.<br>- **CALD1 (Caldesmon 1)**: Involved in smooth muscle contraction.<br>- **PDLIM4**: Involved in cytoskeletal organization.<br>- **ANXA1 (Annexin A1)**: Involved in anti-inflammatory responses.<br>- **NCL (Nucleolin)**: Involved in ribosome biogenesis and cell proliferation.<br><br>### Step 2: List the Key Cell Type Markers<br>- **KRT17, KRT14, KRT5**: Strongly associated with basal epithelial cells, particularly basal-like breast cancer cells.<br>- **ACTA2, TAGLN**: Indicative of myoepithelial cells or myofibroblasts.<br>- **CAV1, CAV2**: Often expressed in stromal cells, including fibroblasts and myoepithelial cells.<br>- **SAA1, CXCL8, CXCL2, CXCL1**: Associated with inflammatory responses, possibly indicating immune cell involvement or a reactive stroma.<br><br>### Step 3: Cross-reference Known Databases<br>Using databases such as the Human Protein Atlas, CellMarker, and literature on breast cancer cell types:<br>- **Basal-like breast cancer cells**: Known to express KRT5, KRT14, and KRT17.<br>- **Myoepithelial cells**: Express ACTA2, TAGLN, and sometimes KRT14.<br>- **Fibroblasts and stromal cells**: Express CAV1, CAV2, and integrins.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of keratins (KRT5, KRT14, KRT17) and ACTA2, the most probable general cell type is **basal epithelial cells**. These markers are characteristic of basal-like breast cancer cells, which are a subtype of epithelial cells.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Basal-like Breast Cancer Cells**: High expression of KRT5, KRT14, and KRT17 strongly suggests this subtype.<br>2. **Myoepithelial Cells**: Expression of ACTA2 and TAGLN suggests a myoepithelial phenotype, which can overlap with basal-like characteristics.<br>3. **Reactive Stromal Cells (e.g., Myofibroblasts)**: Expression of ACTA2, TAGLN, and CAV1/CAV2 suggests a stromal component, possibly reactive to the tumor environment.<br><br>**Most Likely Subtype**: Basal-like Breast Cancer Cells<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of basal epithelial cells, specifically basal-like breast cancer cells. This is supported by the high expression of keratins KRT5, KRT14, and KRT17, which are hallmark markers of this subtype. Additionally, the presence of ACTA2 and TAGLN indicates a potential myoepithelial or myofibroblast component, which is common in the tumor microenvironment. The expression of inflammatory markers such as SAA1 and chemokines suggests an active tumor stroma.<br><br>FINAL ANNOTATION COMPLETED
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:<br><br>1. **Marker Consistency**: <br>   - The key markers used in the annotation (KRT17, KRT14, KRT5, ACTA2, TAGLN, CAV1, CAV2, etc.) are present in the provided marker list.<br>   - The markers are appropriately associated with the identified cell types, such as basal epithelial cells and myoepithelial cells.<br><br>2. **Mixed Cell Type Consideration**:<br>   - The annotation acknowledges the potential presence of mixed cell types, such as myoepithelial cells and reactive stromal cells, which is supported by the expression of ACTA2, TAGLN, and CAV1/CAV2.<br>   - The presence of inflammatory markers (SAA1, CXCL8, CXCL2, CXCL1) suggests a reactive stroma, which is a reasonable consideration given the context of breast cancer tissue.<br><br>The annotation process has been thorough, considering both the primary cell type and potential mixed populations, and aligns well with known databases and literature. Therefore, the validation is passed.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">Basal Epithelial Cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>Basal-like Breast Cancer Cells</li><li>Myoepithelial Cells</li><li>Reactive Stromal Cells (e.g., Myofibroblasts)</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">95</div>
                        <div class="scoring-content">
                            The annotation results provided demonstrate a comprehensive and well-reasoned approach to identifying the cell types present in the single-cell dataset from human breast cancer tissue. The analysis effectively utilizes a wide range of markers, ensuring a balanced consideration of multiple factors rather than over-focusing on a specific marker. This is evident in the detailed breakdown of key functional markers and their association with specific cell types, such as the use of keratins (KRT17, KRT14, KRT5) to identify basal epithelial cells and ACTA2 and TAGLN to suggest myoepithelial or myofibroblast components.<br><br>The annotation correctly identifies the main cell type as basal epithelial cells, specifically basal-like breast cancer cells, which aligns with the known expression patterns of the markers listed. The consideration of potential mixed cell types, such as myoepithelial cells and reactive stromal cells, further enhances the accuracy of the annotation by acknowledging the complexity of the tumor microenvironment.<br><br>The analysis also appropriately considers the rank and importance of the markers, with key markers like KRT17, KRT14, and KRT5 appearing early in the list, indicating their significance in the annotation process. The inclusion of inflammatory markers (SAA1, CXCL8, CXCL2, CXCL1) and their role in suggesting a reactive stroma is a thoughtful addition that captures the broader picture of the cell populations present.<br><br>Overall, the annotation is scientifically accurate, well-balanced, and provides a comprehensive view of the cell types present in the dataset. There are no obvious misclassifications or oversights, and the validation process confirms the robustness of the results.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    